Clincosm LogoSign in Get a demo

Recurrent Plasma Cell Myeloma

Showing 51 - 70 of 70
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (Dexamethasone, Lenalidomide, Thalidomide)

Completed
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2020

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Indianapolis, Rochester, Wauwatosa (Bortezomib,

Withdrawn
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Indianapolis, Indiana
  • +2 more
Sep 29, 2020

HLA-A*0201 Positive Cells Present, NY-ESO-1 Positive Tumor Cells Present, Recurrent Plasma Cell Myeloma Trial in Los Angeles

Withdrawn
  • HLA-A*0201 Positive Cells Present
  • +3 more
  • 18F-FHBG
  • +10 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 22, 2020

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (Carfilzomib, Dexamethasone, Laboratory

Completed
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Fairbanks, Alaska
  • +484 more
Apr 3, 2020

Hematopoietic Cell Transplantation Recipient, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Columbus

Withdrawn
  • Hematopoietic Cell Transplantation Recipient
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 19, 2020

Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute

Completed
Has Results
  • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +5 more
  • Therapeutic Allogeneic Lymphocytes
  • Seattle, Washington
  • +3 more
Jan 15, 2020

Aggressive Non-Hodgkin Lymphoma, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Chronic Lymphocytic Leukemia Trial in

Completed
Has Results
  • Aggressive Non-Hodgkin Lymphoma
  • +20 more
  • Atorvastatin Calcium
  • +7 more
  • Denver, Colorado
  • +1 more
Dec 26, 2019

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in United States (procedure, drug,

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +25 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Aurora, Colorado
  • +5 more
Dec 17, 2019

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma Trial in Denmark, Germany, United States

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +18 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +6 more
  • Denver, Colorado
  • +10 more
Oct 10, 2019

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Scottsdale, Jacksonville, Rochester (Cyclophosphamide,

Completed
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Scottsdale, Arizona
  • +2 more
Aug 29, 2019

Plasma Cell Leukemia, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (Carfilzomib, Filanesib,

Completed
  • Plasma Cell Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 12, 2019

B-Cell Prolymphocytic Leukemia, Hypodiploidy, Loss of Chromosome 17p Trial in Seattle, Milwaukee (procedure, drug, other,

Completed
Has Results
  • B-Cell Prolymphocytic Leukemia
  • +20 more
  • Allogeneic Bone Marrow Transplantation
  • +14 more
  • Seattle, Washington
  • +1 more
May 31, 2019

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Columbus (other, drug, biological)

Terminated
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Laboratory Biomarker Analysis
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 29, 2019

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma, t(11;14) Negative Trial (Dexamethasone, Ixazomib, Ixazomib

Withdrawn
  • Recurrent Plasma Cell Myeloma
  • +2 more
  • (no location specified)
Mar 25, 2019

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Dexamethasone, Lenalidomide, Pomalidomide)

Completed
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Rochester, Minnesota
    Mayo Clinic
Aug 14, 2018

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Winston-Salem (Laboratory Biomarker Analysis,

Withdrawn
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Laboratory Biomarker Analysis
  • +2 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jun 29, 2018

Recurrent Plasma Cell Myeloma Trial in United States (Bortezomib, Dexamethasone, Dinaciclib)

Completed
  • Recurrent Plasma Cell Myeloma
  • Scottsdale, Arizona
  • +5 more
May 10, 2018

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Portland (Cyclophosphamide, Dexamethasone,

Completed
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Portland, Oregon
    OHSU Knight Cancer Institute
Sep 5, 2017

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in United States (Laboratory Biomarker Analysis,

Completed
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Tampa, Florida
  • +8 more
Jul 24, 2015

Plasma Cell Myeloma, Plasmacytosis, Recurrent Plasma Cell Myeloma Trial in Aurora (Melphalan, Bortezomib, Dexamethasone)

Terminated
Has Results
  • Plasma Cell Myeloma
  • +3 more
  • Aurora, Colorado
    University of Colorado Cancer Center
Feb 23, 2015